Multimodal Raman and Fluorescence Lifetime Imaging: A New Analytical Approach for Resolving Timing-Dependent Metabolic Recovery in Endothelial Dysfunction.

Authors

Anna Pieczara, Julian Plitzko, Aleksandra Borek-Dorosz, Krzysztof Brzozowski, Marko Rodewald, Hyeonsoo Bae, Tobias Meyer-Zedler, Michael Schmitt, Jurgen Popp, Malgorzata Baranska

Published in

Analytical chemistry. Jul 27, 2026. Epub Jul 27, 2026.

Abstract

Endothelial dysfunction involves profound metabolic and biochemical disturbances that disrupt vascular homeostasis, yet temporal recovery patterns remain analytically underexplored. This study presents a high-content analytical platform integrating spontaneous Raman scattering, stimulated Raman scattering, coherent anti-Stokes Raman scattering, and fluorescence lifetime imaging microscopy to quantitatively map molecular alterations associated with endothelial dysfunction in vitro. The multimodal approach enables simultaneous assessment of lipid metabolism, biochemical composition, and cellular bioenergetics with subcellular spatial resolution. Distinct spectral biomarkers were identified, including diagnostic Raman bands at 701, 1748, 2884, and 3011 cm^-1, complemented by nonspectral descriptors such as reduced cell volume and accelerated lipid droplet formation. Chemometric analysis utilizing principal component analysis, partial least-squares regression, and semiquantitative lipid profiling revealed a pronounced timing-dependent response to enalaprilat. Preventive treatment was found to preserve metabolic integrity, whereas post-treatment induced only partial restitution and generated a divergent metabolic trajectory. These findings demonstrate that early intervention leads to analytically distinguishable molecular states, underscoring the relevance of temporal profiling in endothelial diagnostics. By establishing a multimodal spectroscopic and chemometric framework, this work highlights the analytical power of integrative imaging for resolving subtle metabolic phenotypes and refining strategies for the objective evaluation of therapeutic efficacy.

PMID:
42504555
Bibliographic data and abstract were imported from PubMed on 27 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.